Literature DB >> 12130773

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

John Hardy1, Dennis J Selkoe.   

Abstract

It has been more than 10 years since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid beta-peptide (Abeta) in plaques in brain tissue. According to the amyloid hypothesis, accumulation of Abeta in the brain is the primary influence driving AD pathogenesis. The rest of the disease process, including formation of neurofibrillary tangles containing tau protein, is proposed to result from an imbalance between Abeta production and Abeta clearance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12130773     DOI: 10.1126/science.1072994

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  2000 in total

1.  Polyadenylation of nascent RNA during the embryogenesis of Ilyanassa obsoleta.

Authors:  J R Collier
Journal:  Exp Cell Res       Date:  1975-10-15       Impact factor: 3.905

2.  Short peptide amyloid organization: stabilities and conformations of the islet amyloid peptide NFGAIL.

Authors:  David Zanuy; Buyong Ma; Ruth Nussinov
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

3.  Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.

Authors:  Santiago V Salazar; Timothy O Cox; Suho Lee; A Harrison Brody; Annabel S Chyung; Laura T Haas; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2018-12-05       Impact factor: 6.167

Review 4.  It's complicated: The relationship between sleep and Alzheimer's disease in humans.

Authors:  Brendan P Lucey
Journal:  Neurobiol Dis       Date:  2020-07-29       Impact factor: 5.996

5.  Tautomeric Effect of Histidine on β-Sheet Formation of Amyloid Beta 1-40: 2D-IR Simulations.

Authors:  Yeonsig Nam; Mahroof Kalathingal; Shinji Saito; Jin Yong Lee
Journal:  Biophys J       Date:  2020-07-18       Impact factor: 4.033

6.  ApoE4 Accelerates Early Seeding of Amyloid Pathology.

Authors:  Chia-Chen Liu; Na Zhao; Yuan Fu; Na Wang; Cynthia Linares; Chih-Wei Tsai; Guojun Bu
Journal:  Neuron       Date:  2017-12-06       Impact factor: 17.173

7.  Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists.

Authors:  Erik C Gunther; Levi M Smith; Mikhail A Kostylev; Timothy O Cox; Adam C Kaufman; Suho Lee; Ewa Folta-Stogniew; George D Maynard; Ji Won Um; Massimiliano Stagi; Jacqueline K Heiss; Austin Stoner; Geoff P Noble; Hideyuki Takahashi; Laura T Haas; John S Schneekloth; Janie Merkel; Christopher Teran; Zahra K Naderi; Surachai Supattapone; Stephen M Strittmatter
Journal:  Cell Rep       Date:  2019-01-02       Impact factor: 9.423

Review 8.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

9.  Cerebral amyloid angiopathy in an aged sooty mangabey (Cercocebus atys).

Authors:  Olivia M D'Angelo; Jeromy Dooyema; Cynthia Courtney; Lary C Walker; Eric Heuer
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

Review 10.  Alzheimer's silent partner: cerebral amyloid angiopathy.

Authors:  Tanya L Cupino; Matthew K Zabel
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.